Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline — Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. CLSI document M29-A3.
Abrams C, Deng Y-J, Steiner B, O’Toole T, Shattil SJ. Determinants of specificity of a baculovirus-expressed antibody Fab fragment that binds selectively to the activated form of integrin αIIb β3. J Biol Chem. 1994;269:18781-18788.
Abrams C, Shattil SJ. Immunological detection of activated platelets in clinical disorders. Thrombosis and Haemostasis. 1991;65:467-473.
Abrams CS, Ellison N, Budzinski AZ, Shattil SJ. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood. 1990;75:128-138.
Abrams CS, Ruggeri ZM, Taub R, et al. Anti-idiotypic antibodies against an antibody to the platelet glycoprotein (GP) IIb-IIIa complex mimic GP IIb-IIIa by recognizing fibrinogen. J Biol Chem. 1990;75:128-138.
Bennett JS, Shattil SJ, Power JW, Gartner TK. Interaction of fibrinogen with its platelet receptor. J Biol Chem. 1988;263:12948-12953.
Centers for Disease Control. Perspectives in disease prevention and health promotion update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. MMWR. 1988;37:377-388.
Ginsberg MH, Frelinger AL, Lam S, et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood. 1990;76:2017-2023.
Huang M-M, Lipfert L, Cunningham M, et al. Adhesive ligand binding to integrin αIIbβ3 stimulates tyrosine phosphorylation of novel protein substrates before phosphorylation of pp125FAK. J Cell Biol. 1993;122:473-483.
Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
Michelson AD. Flow cytometry: A clinical test of platelet function. Blood. 1996;87:4925-4936.
O’Toole TE, Mandelman D, Forsyth J, et al. Modulation of the affinity of integrin α IIb β 3 (GPIIb-IIIa) by the cytoplasmic domain of αIIb. Science. 1991;254:845-847.
Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;70:307-315.
Shattil SJ, Cunningham M. Wiedmer T, et al. Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. J Biol Chem. 1992;267:18424-18431.
Shattil SJ, Hoxie JA, Cunningham M, Brass L. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem. 1985;260:11107-11114.
Shattil SJ, Weisel JW, Kieber-Emmons T. Use of monoclonal antibodies to study the interaction between an integrin adhesion receptor, GP IIb-IIIa, and its physiological ligand, fibrinogen. Immunomethods. 1993;1:53-63.
Springer TA. Adhesion receptors of the immune system. Nature. 1990;346:425-433.
Taub R, Gould RJ, Garsky VM, et al. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem. 1989;264:259-265.
